Zaher Nuwayhid, director of the Conway Medical Center Weight Loss Program, the expanded access reflects a growing understanding that obesity deserves the same medical attention as other chronic diseases
Maintenance of weight loss: once therapeutic levels have helped patients achieve their goal weight, lowering the dose may be a helpful longer-term way of keeping them there
for example, GLP1-FGF21 (DDKJ Biomedicals, HEC Pharm), GLP1-GCG-FGF21 (Doer Biologics), and GLP1-GIP-FGF21 (DDKJ Biomedicals)
+ NAC supports liver function by rebuilding glutathione, and small trials show improved liver enzymes in fatty liver over 3 to 6 months
SURMOUNT-1 data show meaningful weight loss at all three maintenance dose tiers: approximately 15% at 5 mg, 19.5% at 10 mg, and 20.9% at 15 mg